Figure 1.

(a–l): A 34-year-old male presented with bilateral JRCH with macular edema with BCVA of 20/60 and 20/20 in OD and OS, respectively. Fluorescein angiography (FA) demonstrated early hyperfluorescence of the tumor vessels and progressive leakage in the late phase of the angiogram, as shown in Figs. 1(b), 1(c), 1(h), and 1(i). He underwent ICG-guided TTT with intravitreal bevacizumab in both eyes. At 6 weeks follow-up, SRF was persisting; hence, a repeat sitting of ICG-TTT with intravitreal dexamethasone implant was given. At 12 weeks, the BCVA was stable with complete resolution of SRF and tumor control